CRP and rheumatoid arthritis: At t-12, the moderate disease activity raised CRP, and glucocorticoid criteria were fulfilled by 14/30 (46.7%), 11/30 (36.7%), and 20/30 (66.7%) D2T-RA patients, respectively.